Literature DB >> 33389382

The KLF14 Variant is Associated with Type 2 Diabetes and HbA1C Level.

Ensieh Shahvazian1, Mohammad Bagher Mahmoudi2, Ehsan Farashahi Yazd3,4,5, Saba Gharibi1, Bahram Moghimi2, Pouria HosseinNia6, Masoud Mirzaei7.   

Abstract

The purpose of this study was to scan variants in coding region of Krȕppel like factor14 (KLF14) locus and assess association related to type 2 diabetes (T2D) in Iranian population. We sequenced the coding region of KLF14 to scan variants in case-sibling study (92 individuals with T2D and 92 healthy older siblings). To confirm, we analyzed rs76603546 association with T2D in a larger unrelated case-control study by PCR-RFLP (475 cases and 512 controls). We analyzed the association of rs76603546 with HbA1C, BMI, fat mass, waist circumference, fasting glucose, cholesterol and HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) using one-way ANOVA analysis. Also, association of genotypes with T2D adjusted for confounding variables was analyzed using logistic regression. HaploReg v 4.1 was used to predict rs76603546 possible function. Sequencing results analysis revealed the association of C allele of rs76603546, synonymous variant C>T, [OR 2.10 (1.38-3.20), P value < 0.001] and CC genotype of rs76603546 [OR 4.3 (1.79-10.23), P value = 0.001] with susceptibility to T2D. PCR-Restriction Fragment Length Polymorphism (RFLP) results analysis confirmed the association of rs76603546 with T2D [C allele, OR 1.91 (1.59-2.29), P value = 0.002, CC genotype, OR 3.27 (2.26-4.73), P value = 0.002 and TC genotype, OR 1.74 (1.31-2.31), P value = 0.001]. The CC genotype of rs76603546 is associated with HbA1C level (P value < 0.001) and BMI (P value = 0.02). After adjustment with confounding variables, we observed association of CC genotype with T2D [OR 2.542 (1.25-3.77), P value = 0.03]. Among over 220 SNPs, rs76603546 was associated with T2D, HbA1C and BMI in our study.

Entities:  

Keywords:  Association; Body mass index; HbA1C; Type2 diabetes; rs76603546

Mesh:

Substances:

Year:  2021        PMID: 33389382     DOI: 10.1007/s10528-020-10015-w

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  36 in total

1.  The TCF7L2 diabetes risk variant is associated with HbA₁(C) levels: a genome-wide association meta-analysis.

Authors:  Christopher S Franklin; Yurii S Aulchenko; Jennifer E Huffman; Veronique Vitart; Caroline Hayward; Ozren Polašek; Sara Knott; Lina Zgaga; Tatijana Zemunik; Igor Rudan; Harry Campbell; Alan F Wright; Sarah H Wild; James F Wilson
Journal:  Ann Hum Genet       Date:  2010-09-16       Impact factor: 1.670

2.  Breastfeeding protects against type 1 diabetes mellitus: a case-sibling study.

Authors:  João Guilherme Bezerra Alves; José Natal Figueiroa; Jucille Meneses; Guilherme Victor Alves
Journal:  Breastfeed Med       Date:  2011-08-05       Impact factor: 1.817

3.  New role for Kruppel-like factor 14 as a transcriptional activator involved in the generation of signaling lipids.

Authors:  Thiago M de Assuncao; Gwen Lomberk; Sheng Cao; Usman Yaqoob; Angela Mathison; Douglas A Simonetto; Robert C Huebert; Raul A Urrutia; Vijay H Shah
Journal:  J Biol Chem       Date:  2014-04-23       Impact factor: 5.157

4.  A statistical approach for rare-variant association testing in affected sibships.

Authors:  Michael P Epstein; Richard Duncan; Erin B Ware; Min A Jhun; Lawrence F Bielak; Wei Zhao; Jennifer A Smith; Patricia A Peyser; Sharon L R Kardia; Glen A Satten
Journal:  Am J Hum Genet       Date:  2015-03-19       Impact factor: 11.025

5.  Conducting the metabolic syndrome orchestra.

Authors:  Mete Civelek; Aldons J Lusis
Journal:  Nat Genet       Date:  2011-06       Impact factor: 38.330

6.  Involvement of KLF14 and egr-1 in the TGF-beta1 action on Leydig cell proliferation.

Authors:  C R Gonzalez; S S Vallcaneras; R S Calandra; S I Gonzalez Calvar
Journal:  Cytokine       Date:  2013-01-11       Impact factor: 3.861

7.  Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.

Authors:  Jubao Duan; Mark S Wainwright; Josep M Comeron; Naruya Saitou; Alan R Sanders; Joel Gelernter; Pablo V Gejman
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

8.  Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.

Authors:  Yanhong Guo; Yanbo Fan; Jifeng Zhang; Gwen A Lomberk; Zhou Zhou; Lijie Sun; Angela J Mathison; Minerva T Garcia-Barrio; Ji Zhang; Lixia Zeng; Lei Li; Subramaniam Pennathur; Cristen J Willer; Daniel J Rader; Raul Urrutia; Y Eugene Chen
Journal:  J Clin Invest       Date:  2015-09-14       Impact factor: 14.808

9.  Genome-wide meta-analysis in Japanese populations identifies novel variants at the TMC6-TMC8 and SIX3-SIX2 loci associated with HbA1c.

Authors:  Tsuyoshi Hachiya; Shohei Komaki; Yutaka Hasegawa; Hideki Ohmomo; Kozo Tanno; Atsushi Hozawa; Gen Tamiya; Masayuki Yamamoto; Kuniaki Ogasawara; Motoyuki Nakamura; Jiro Hitomi; Yasushi Ishigaki; Makoto Sasaki; Atsushi Shimizu
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

Review 10.  Chapter 11: Genome-wide association studies.

Authors:  William S Bush; Jason H Moore
Journal:  PLoS Comput Biol       Date:  2012-12-27       Impact factor: 4.475

View more
  3 in total

1.  KLF14 targets ITGB1 to inhibit the progression of cervical cancer via the PI3K/AKT signalling pathway.

Authors:  Xinran Lyu; Xuchao Ding; Hui Ye; Rong Guo; Minhang Wu; Lili Cao
Journal:  Discov Oncol       Date:  2022-05-16

2.  Consanguinity and Diabetes in Saudi Population: A Case-Control Study.

Authors:  Saad H Alzahrani; Nawaf M Alzahrani; Fahad M Al Jabir; Mohammed K Alsharef; Shawana Zaheer; Salma H Hussein; Abdullah M Alguwaihes; Anwar A Jammah
Journal:  Cureus       Date:  2021-12-30

3.  APOE and KLF14 genetic variants are sex-specific for low high-density lipoprotein cholesterol identified by a genome-wide association study.

Authors:  Ying-Hui Lee; Ya-Sian Chang; Chih-Chang Hsieh; Rong-Tsorng Wang; Jan-Gowth Chang; Chung-Jen Chen; Shun-Jen Chang
Journal:  Genet Mol Biol       Date:  2022-02-21       Impact factor: 1.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.